CEO
James Hamet, a visionary neurotech entrepreneur, founded Vistim Labs, leveraging AI and software to redefine dementia evaluation. With a notable track record, including co-founding the $100M Neurable, James' journey began in empowering paralyzed patients and expanded to groundbreaking diagnostics. A respected neurotechnology expert, he collaborates globally and has authored impactful research. Vistim Labs addresses inconclusive neurological tests through AI-driven predictive screening. James epitomizes a tech CEO committed to innovation, bridging research and practical healthcare solutions.
Tune in to the conversation between host Wade Erickson and James Hamet, CEO of Vistin Labs, about the role of AI in medicine, patient protection, and clinical excellence.